Novel Drug Could Be ' Disease Modifying ' in Sickle Cell Disease Novel Drug Could Be ' Disease Modifying ' in Sickle Cell Disease

An investigational agent, the first-in-class drug voxelotor, is seen as potentially ‘ disease-modifying ' as it targets mechanisms that cause anemia.Medscape Medical News
Source: Medscape Hematology-Oncology Headlines - Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news